Related Experiment Videos
Clinical and laboratory evaluation of renal stone patients
1Division of Nephrology, Mayo Clinic, Rochester, Minnesota.
Insights
Managing kidney stones (renal lithiasis) requires lifelong physician monitoring of risk factors. Aggressive management can make 95% of patients metabolically inactive, reducing long-term costs.
Area of Science:
- Nephrology
- Urology
- Metabolic Medicine
Background:
- Renal lithiasis management presents lifelong challenges for patients and physicians.
- Monitoring stone formation and risk factors requires sustained physician involvement.
- Inadequate management incurs significant economic burdens on patients and society.
Purpose of the Study:
- To highlight the necessity of long-term, physician-led management for renal lithiasis.
- To emphasize the economic implications of effective versus ineffective stone disease management.
- To discuss the evolving strategies for assessing and managing metabolic risk factors in stone formers.
Main Methods:
- Long-term clinical observation of patients with renal lithiasis.
- Analysis of risk factors contributing to stone formation.
- Assessment of therapeutic interventions for metabolic management.
Main Results:
- Aggressive risk factor management and follow-up can render 95% of patients metabolically inactive.
- Effective management significantly reduces the economic burden associated with renal lithiasis.
- Current risk factor indices lack clearly established efficacy.
Conclusions:
- Lifelong physician association is crucial for effective renal lithiasis management.
- Proactive risk factor management is key to achieving metabolic inactivity in most patients.
- Further research is needed to establish reliable risk factor indices for stone disease.
Abstract:
The management of renal lithiasis is a life-long proposition for most patients. Stone diseases are difficult for both patients and physicians to monitor and treat appropriately. The long-term management of metabolically active patients requires close association with a physician who is prepared to monitor stone formation, appropriate risk factors, and the progress of those risk factors over an extended time. Although this is a large economic commitment, it has been calculated that failure to carry out this responsibility is an even larger economic burden for patients and society. With aggressive risk factor management and follow-up, 95% of patients can become metabolically inactive. The long-term management of these patients, still evolving, is going to continue to require some assessment of the presence or absence of stones. The analysis of risk factors and the assessment of therapeutic maneuvers should continue to improve. It is possible that some specific index of risk factors for these patients will become readily available. Unfortunately, the efficacy of the ones currently available have not been clearly established.